REQUEST A DEMO
Total
USD $0.00
Search more companies

Pfizer, Spol. S R.O. (Czech Republic)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Pfizer, Spol. S R.O. Profile Updated: August 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pfizer Spol. S R.O. is a biofarmaceutical company. The company focuses on research and development of its own medicines, with a global portfolio of medicines in areas including neurological hematology. Pfizer Spol. S R.O. is committed to developing new, innovative drugs, including biological drugs and vaccines, with a strong focus on cancer medications and hematoonkology. The company also produces the FSME-IMMUN vaccine and has developed modified forms of the COMIRNATY vaccine.

Headquarters
Stroupeznickeho 3191/17
Prague; The City of Prague; Postal Code: 15000

Contact Details: Purchase the Pfizer, Spol. S R.O. report to view the information.

Website: http://www.pfizer.cz

Basic Information
Total Employees:
Purchase the Pfizer, Spol. S R.O. report to view the information.
Registered Capital:
Purchase the Pfizer, Spol. S R.O. report to view the information.
Financial Auditors:
Purchase the Pfizer, Spol. S R.O. report to view the information.
Incorporation Date:
May 28, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pfizer, Spol. S R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
4.83%
Total operating revenue
4.82%
Operating profit (EBIT)
2.92%
EBITDA
2.77%
Net Profit (Loss) for the Period
18.97%
Total assets
0.56%
Total equity
-13.75%
Operating Profit Margin (ROS)
-0.06%
Net Profit Margin
0.42%
Return on Equity (ROE)
2.14%
Quick Ratio
-1.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?